Skip to main content
IC
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.875
-0.105 (-5.30%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Immunotheraphies
2.24M
Log In
Log In
Log In
Immunotheraphies Growth
-90.63%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
United States
2.24M
Log In
Log In
Log In
United States Growth
-90.63%
Log In
Log In
Log In